Amanote Research
Register
Sign In
MK-8353: Discovery of an Orally Bioavailable Dual Mechanism ERK Inhibitor for Oncology
doi 10.1021/acsmedchemlett.8b00220.s001
Full Text
Open PDF
Abstract
Available in
full text
Date
Unknown
Authors
Unknown
Publisher
American Chemical Society (ACS)
Related search
Discovery and Evaluation of BMS-708163, a Potent, Selective and Orally Bioavailable Γ-Secretase Inhibitor
ACS Medicinal Chemistry Letters
Organic Chemistry
Biochemistry
Drug Discovery
Discovery of Potent Anticancer Agent HJC0416, an Orally Bioavailable Small Molecule Inhibitor of Signal Transducer and Activator of Transcription 3 (STAT3)
European Journal of Medicinal Chemistry
Medicine
Organic Chemistry
Drug Discovery
Pharmacology
An Orally Bioavailable C-Met Kinase Inhibitor Potently Inhibits Brain Tumor Malignancy and Growth
Anti-Cancer Agents in Medicinal Chemistry
Cancer Research
Molecular Medicine
Pharmacology
Fragment-Based Drug Design and Identification of HJC0123 , a Novel Orally Bioavailable STAT3 Inhibitor for Cancer Therapy
European Journal of Medicinal Chemistry
Medicine
Organic Chemistry
Drug Discovery
Pharmacology
Discovery of an Orally Active Small-Molecule Irreversible Inhibitor of Protein Disulfide Isomerase for Ovarian Cancer Treatment
Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
Discovery of a BTK/MNK Dual Inhibitor for Lymphoma and Leukemia
Leukemia
Cancer Research
Oncology
Anesthesiology
Pain Medicine
Hematology
The Endocannabinoid Reuptake Inhibitor WOBE437 Is Orally Bioavailable and Exerts Indirect Polypharmacological Effects via Different Endocannabinoid Receptors
Frontiers in Molecular Neuroscience
Molecular Neuroscience
Molecular Biology
Cellular
Antiangiogenic Properties of 17-(Dimethylaminoethylamino)-17-Demethoxygeldanamycin: An Orally Bioavailable Heat Shock Protein 90 Modulator
Clinical Cancer Research
Cancer Research
Oncology
A Phase I Trial and PK Study of Cediranib (AZD2171), an Orally Bioavailable Pan-Vegfr Inhibitor, in Children With Recurrent or Refractory Primary CNS Tumors
Child's Nervous System
Medicine
Child Health
Neurology
Pediatrics
Perinatology
